l-alanine supplementation in late infantile glycogen storage disease type II
Abstract
We report a male with late infantile glycogen storage disease type II (Pompe’s disease) who presented at 12 months of age with muscular hypotonia and developmental delay. Oral supplementation with l-alanine has been administered for 5 years. Progression of skeletal myopathy was slow, and cardiomyopathy resolved almost completely. l-alanine may be a valuable supplement for infants with glycogen storage disease type II.
To access this article, please choose from the options below
PII: S0887-8994(02)00413-7
© 2002 Elsevier Science Inc. All rights reserved.
